The association between high SCD1 expression in cancer tissue samples and poor clinical prognosis was also observed in bladder cancer [168], prostate cancer [169], pancreatic cancer [170], ovarian cancer [171], lung cancer [172], colorectal cancer [173], clear cell renal cell carcinoma [174,175], and cervical cancer [176]. This evidence concerns the gene SCD and colorectal cancer.